Crossmark

Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database

Crossref DOI link: https://doi.org/10.1007/s11096-026-02103-5

Published Online: 2026-02-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hao, Zhenghua

Jiang, Kaiyao

Zhang, Junfeng

Zhao, Linmei
License Information

Text and Data Mining valid from 2026-02-26

Version of Record valid from 2026-02-26
More Information

Article History

Received: 24 November 2025

Accepted: 25 January 2026

First Online: 26 February 2026

Declaration

:

: The authors declare no competing interests.

: This study used publicly available anonymized data from the FAERS database and therefore did not require institution al ethics approval.

Document is current

Any future updates will be listed below